Relx plc (REL)

Sector:

Media

Index:

FTSE 100

3,323.00p
   
  • Change Today:
      18.00p
  • 52 Week High: 3,504.00
  • 52 Week Low: 2,434.00
  • Currency: UK Pounds
  • Shares Issued: 1,877.40m
  • Volume: 795,025
  • Market Cap: £62,386m
  • RiskGrade: 128

Monday broker round-up

By Caoimhe Toman

Date: Monday 17 Feb 2020

LONDON (ShareCast) - (Sharecast News) - Hikma Pharmatheuticals: Citigroup downgrades to neutral with a target price of 1,980p.

Jupiter Fund Management: Berenberg reiterates hold with a target price of 367p.

Centamin: Berenberg reiterates hold with a target price of 127p.

Hummingbird Resources: Berenberg reiterates buy with a target price of 38p.

MJ Gleeson: Canaccord reiterates hold with a target price of 960p.

Imperial Brands: Deutsche Bank reiterates buy with a target price of 2,400p.

National Grid: Barclays reiterates overweight with a target price of 1,115p.

Segro: Deutsche Bank downgrades to hold with a target price of 810p.

AstraZeneca: UBS reiterates sell with a target price of 5,800p.

Just Eat: Barclays reiterates overweight with a target price 8,500p.

Reckitt Benckiser Group: JP Morgan reiterates overweight with a target price of 8,500p.

Royal Bank of Scotland: JP Morgan reiterates overweight with a target price of 260p.

Ashtead: JP Morgan reiterates overweight with a target price of 3,250p.

Dunelm: RBC reiterates sector performer with a target price of 1,250p.

RELX: UBS reiterates sell with a target price of 1,825p.

Barclays: UBS reiterates buy with a target price of 205p.

Associated British Foods: UBS reiterates buy with a target price of 3,200p.

Meggitt: Citigroup downgrades to neutral with a target price of 730p.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Reed Elsevier Market Data

Currency UK Pounds
Share Price 3,323.00p
Change Today 18.00p
% Change 0.54 %
52 Week High 3,504.00
52 Week Low 2,434.00
Volume 795,025
Shares Issued 1,877.40m
Market Cap £62,386m
RiskGrade 128

Reed Elsevier Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
99.34% below the market average99.34% below the market average99.34% below the market average99.34% below the market average99.34% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Price Trend
81.20% above the market average81.20% above the market average81.20% above the market average81.20% above the market average81.20% above the market average
82.98% above the sector average82.98% above the sector average82.98% above the sector average82.98% above the sector average82.98% above the sector average
Income
89.71% below the market average89.71% below the market average89.71% below the market average89.71% below the market average89.71% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Growth
18.81% below the market average18.81% below the market average18.81% below the market average18.81% below the market average18.81% below the market average
18.18% below the sector average18.18% below the sector average18.18% below the sector average18.18% below the sector average18.18% below the sector average

What The Brokers Say

Strong Buy 4
Buy 6
Neutral 5
Sell 0
Strong Sell 0
Total 15
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Reed Elsevier Dividends

  Latest Previous
  Final Interim
Ex-Div 02-May-24 03-Aug-23
Paid 13-Jun-24 07-Sep-23
Amount 41.80p 17.00p

Trades for 18-Apr-2024

Time Volume / Share Price
14:27 10 @ 3,323.00p
14:27 138 @ 3,323.00p
14:27 439 @ 3,323.00p
14:26 470 @ 3,323.00p
14:26 94 @ 3,323.00p

Reed Elsevier Key Personnel

CEO Erik Engstrom
CFO N L Luff
Chair Paul Walker

Top of Page